Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,408 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Active, Not Recruiting

Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse

NCT04475731

Conditions
Acute Lymphoblastic Leukemia, in Relapse, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Aou Ospedali Riuniti "Umberto I - G.M. Lancisi - G. Salesi"- Ancona - Sod Clinica Ematologica Ancona, Italy
  • Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia Ascoli Piceno, Italy
  • Ao Di Rilievo Nazionale E Di Alta Specialità "San Giuseppe Moscati" - Avellino - Uoc Ematologia Con Unità Di Trapianto Avellino, Italy
  • Aou Consorziale Policlinico - Bari - Uo Ematologia Con Trapianto Bari, Italy
View all 22 locations
View Trial Details
Active, Not Recruiting

A Study of Ivosidenib or Enasidenib in Combination With Induction Therapy and Consolidation Therapy, Followed by Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myedysplastic Syndrome EB2, With an IDH1 or IDH2 Mutation, Respectively, Eligible for Intensive Chemotherapy

NCT03839771

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • AU-Adelaide-FLINDERS Adelaide, Australia
  • AU-Adelaide-RAH Adelaide, Australia
  • AU-Brisbane-PAH Brisbane, Australia
  • AU-Camperdown-RPA Camperdown, Australia
View all 181 locations
View Trial Details
Active, Not Recruiting

Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia

NCT03789981

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • AO Spedali Civili di Brescia Brescia, BS, Italy
  • Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Meldola, FC, Italy
  • IRCCS Casa sollievo sofferenza San Giovanni Rotondo, FOGGIA, Italy
  • IRCCS AOU S. Martino Genova Genova, GE, Italy
View all 14 locations
View Trial Details
Active, Not Recruiting

Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.

NCT03541083

Conditions
ALL, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • BE-Antwerpen Edegem-UZA Antwerp, Belgium
  • BE-Antwerpen-ZNASTUIVENBERG Antwerp, Belgium
  • BE-Brugge-AZBRUGGE Bruges, Belgium
  • BE-Gent-UZGENT Ghent, Belgium
View all 18 locations
View Trial Details
Active, Not Recruiting

Project Baseline Health Study

NCT03154346

Conditions
ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Baseline Study South San Francisco, California, United States
  • Stanford Medicine Stanford, California, United States
  • California Health and Longevity Institute Westlake Village, California, United States
  • Duke University School of Medicine Durham, North Carolina, United States
View Trial Details

Related conditions